Evidence map›Paper›PMID 33621408›Full record

ArticleJournal of cellular and molecular medicine2021

Adipose triglyceride lipase promotes the proliferation of colorectal cancer cells via enhancing the lipolytic pathway.

Haofan Yin, Wentao Li, Laiming Mo, Shaotuan Deng, Weijia Lin, Caiqi Ma, Zhaofan Luo, Chuanghua Luo, Honghai Hong

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Long non‑coding RNAs, lipid metabolism and cancer (Review).Experimental and therapeutic medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Haofan YinDepartment of Clinical Laboratory, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.ORCID 0000-0003-0800-4455
Wentao LiDepartment of Clinical Laboratory, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Laiming MoDepartment of Clinical Laboratory, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Shaotuan DengDepartment of Clinical Laboratory, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Weijia LinDepartment of Clinical Laboratory, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Caiqi MaReproductive Medical Center, Guangzhou Women and Children's Medical Center of Sun Yat-sen University, Guangzhou, China.
Zhaofan LuoDepartment of Clinical Laboratory, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Chuanghua LuoState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Honghai HongDepartment of Clinical Laboratory, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.ORCID 0000-0003-2138-9118
Sun Yat-sen University · CNThird Affiliated Hospital of Guangzhou Medical University · CN

Funding

Educational Commission of Guangdong Province 2017KTSCX155Guangdong Basic and Applied Basic Research Foundation 2019A1515011318Guangzhou Institute of Pediatrics/Guangzhou Women and Children's Medical Center YIP-2019-021National Nature Science Foundation of China 81902693Natural Science Foundation of Guangdong Province 2018A030310298Shenzhen Science and Technology Innovation Commission Basic Research Foundation JCYJ20180307150637015
6 · The paper itself

Abstract

Abnormal lipid metabolism is the sign of tumour cells. Previous researches have revealed that the lipolytic pathway may contribute to the progression of colorectal cancer (CRC). However, adipose triglyceride lipase (ATGL) role in CRC cells remains unclear. Here, we find that elevated ATGL positively correlates with CRC clinical stages and negatively associates with overall survival. Overexpression of ATGL significantly promotes CRC cell proliferation, while knockdown of ATGL inhibits the proliferation and promotes the apoptosis of CRC cells in vitro. Moreover, in vivo experiments, ATGL promotes the growth of CRC cells. Mechanistically, ATGL enhances the carcinogenic function of CRC cells via promoting sphingolipid metabolism and CoA biosynthesis pathway-related gene levels by degrading triglycerides, which provides adequate nutrition for the progression of CRC. Our researches clarify for the first time that ATGL is a novel oncogene in CRC and may provide an important prognostic factor and therapeutic target for CRC.

Indexed as

Gene Expression Regulation, NeoplasticLipolysisAcyltransferasesAnimalsApoptosisBiomarkers, TumorCell ProliferationColorectal NeoplasmsFemaleHumansLipaseLipid MetabolismMaleMiceMice, Inbred BALB CMice, NudeAcyltransferasesBiomarkers, TumorLipasePNPLA2 protein, humanadipose triglyceride lipasecolorectal cancerlipolyticproliferation

Identifiers

PMID33621408
PMCPMC8051714
OpenAlexW3132828396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.